A 3-day-old male neonate born to non-consanguineous parents presents with poor feeding, lethargy, and vomiting 48 hours after birth. On examination, he is hypotonic with a weak cry. Laboratory investigations reveal: blood ammonia 280 µmol/L (normal <50), pH 7.32, HCO₃⁻ 18 mEq/L, and normal liver function tests. Plasma amino acid profile shows elevated glutamine and alanine. Urine orotic acid is markedly elevated. Which enzyme deficiency is most likely responsible for this presentation?

Explanation

## Clinical Presentation Analysis This neonatal case presents with classic hyperammonemia in the first 72 hours of life with a distinctive biochemical signature. ### Key Diagnostic Clues **High-Yield:** The combination of: - Neonatal hyperammonemia (280 µmol/L) - Elevated plasma glutamine and alanine (ammonia scavengers) - **Markedly elevated urinary orotic acid** — this is the pathognomonic finding - Normal liver function tests (excludes hepatic disease) - Respiratory alkalosis (from hyperammonemia-induced hyperventilation) ### Why Elevated Urinary Orotic Acid Points to OTC Deficiency **Key Point:** In OTC deficiency, carbamoyl phosphate (CP) accumulates because it cannot be condensed with ornithine. Excess CP is shunted into the pyrimidine synthesis pathway, leading to massive orotic acid production and urinary excretion. ```mermaid flowchart TD A[Protein/Amino Acid Catabolism] -->|Ammonia| B[Carbamoyl Phosphate Synthetase I] B -->|Carbamoyl Phosphate| C{OTC Present?}:::decision C -->|Yes| D[Condenses with Ornithine]:::action C -->|No| E[Shunted to Pyrimidine Pathway]:::action D --> F[Urea Cycle Proceeds]:::outcome E --> G[Orotic Acid Accumulation]:::urgent G --> H[Massive Urinary Orotic Acid]:::outcome C -->|No| I[Carbamoyl Phosphate Accumulates]:::urgent I --> J[Hyperammonemia]:::urgent ``` ### Urea Cycle Enzyme Deficiencies — Differential | Enzyme Deficiency | Plasma Ammonia | Urinary Orotic Acid | Plasma Citrulline | Inheritance | |---|---|---|---|---| | **OTC** | ↑↑↑ | ↑↑↑ (markedly) | ↓ | X-linked | | **CPS I** | ↑↑↑ | Normal/low | ↓↓ | Autosomal recessive | | **Argininosuccinate lyase** | ↑↑ | ↑ (mild) | ↑↑ | Autosomal recessive | | **Arginase** | ↑ (mild) | Normal | ↑↑↑ | Autosomal recessive | **Clinical Pearl:** OTC deficiency is the most common urea cycle disorder (~50% of cases) and the only X-linked form — males present severely in neonatal period; heterozygous females may present later with stress-induced hyperammonemia. ### Why This Is OTC, Not CPS I Both present with severe neonatal hyperammonemia, but: - **CPS I deficiency:** Urinary orotic acid is **normal or low** (no carbamoyl phosphate reaches pyrimidine synthesis) - **OTC deficiency:** Urinary orotic acid is **markedly elevated** (carbamoyl phosphate is shunted to pyrimidines) The markedly elevated urotic acid is the discriminating feature. **High-Yield:** Remember: **OTC deficiency = elevated orotic acid; CPS I deficiency = low/normal orotic acid.** ### Management Implications 1. Immediate: Protein restriction, IV arginine (substrate for OTC), sodium benzoate (alternative pathway for ammonia removal) 2. Genetic confirmation: OTC gene sequencing 3. Prenatal diagnosis available for future pregnancies [cite:Robbins 10e Ch 7]